Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group

BACKGROUND: Platinum-based doublet chemotherapy is the standard first-line treatment for advanced non-small cell lung cancer (NSCLC), but earlier studies have suggested that non-platinum combinations are equally effective and better tolerated. We conducted a national, randomised study to compare a n...

Descripción completa

Detalles Bibliográficos
Autores principales: Fløtten, Ø, Grønberg, B H, Bremnes, R, Amundsen, T, Sundstrøm, S, Rolke, H, Hornslien, K, Wentzel-Larsen, T, Aasebø, U, von Plessen, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405221/
https://www.ncbi.nlm.nih.gov/pubmed/22759880
http://dx.doi.org/10.1038/bjc.2012.284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405221/
https://www.ncbi.nlm.nih.gov/pubmed/22759880
http://dx.doi.org/10.1038/bjc.2012.284

Ejemplares similares